Christiana Stamoulis appointed president to Unum Therapeutics

Unum Therapeutics  which is a clinical-stage bio pharmaceutical company focused on the development of novel immunotherapy products designed to utilize the power of  patient’s immune system to cure cancer appointed Christiana Stamoulis to the additional role of President.

Ms. Stamoulis has been Unum’s Chief Financial Officer and Head of Corporate Development since joining the Company in January 2015. In her role as President and Chief Financial Officer, Ms. Stamoulis is responsible for Unum’s business functions including finance, corporate and business development, corporate strategy, legal, investor relations and corporate communications.

Chuck Wilson, PhD, Chief Executive Officer of Unum said “Her appointment as President is a fitting and well-earned recognition of her role and the enormous impact she has had in helping to drive Unum’s rapid progress.”

Ms. Stamoulis has served as Unum’s Chief Financial Officer and Head of Corporate Development since January 2015. Prior to joining Unum, Ms. Stamoulis was the Senior Vice President of Corporate Strategy and Business Development and a member of the Executive Team at Vertex Pharmaceuticals, Inc. Prior to Vertex, she served as a Managing Director in the Investment Banking division of Citigroup where she led the building of its U.S. Life Sciences investment banking practice. Prior to her role at Citigroup, she was a senior investment banker in the Healthcare group of the Investment Banking division of Goldman, Sachs & Co. where she spent the majority of her investment banking career.